Trial Profile
Safety and efficacy study of rivaroxaban in patients with long standing persistent atrial fibrillation during ablation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 28 Aug 2015 New trial record